Editorial for the Special Issue: “The Issue of Multidrug-Resistant Pathogens in Nosocomial Infections”
Data Availability Statement
Conflicts of Interest
References
- Antimicrobial Resistance Collaborators. Global burden of bacterial antimicrobial resistance in 2019: A systematic analysis. Lancet 2022, 399, 629–655. [Google Scholar] [CrossRef] [PubMed]
- Bassetti, M.; Giacobbe, D.R.; Bruzzi, P.; Barisione, E.; Centanni, S.; Castaldo, N.; Corcione, S.; De Rosa, F.G.; Di Marco, F.; Gori, A. Clinical management of adult patients with COVID-19 outside intensive care units: Guidelines from the Italian Society of Anti-Infective Therapy (SITA) and the Italian Society of Pulmonology (SIP). Infect. Dis. Ther. 2021, 10, 1837–1885. [Google Scholar] [CrossRef] [PubMed]
- Lai, C.C.; Chen, S.Y.; Ko, W.C.; Hsueh, P.R. Increased antimicrobial resistance during the COVID-19 pandemic. Int. J. Antimicrob. Agents 2021, 57, 106324. [Google Scholar] [CrossRef] [PubMed]
- Maraolo, A.E.; Licciardi, F.; Gentile, I.; Saracino, A.; Belati, A.; Bavaro, D.F. Stenotrophomonas maltophilia Infections: A Systematic Review and Meta-Analysis of Comparative Efficacy of Available Treatments, with Critical Assessment of Novel Therapeutic Options. Antibiotics 2023, 12, 910. [Google Scholar] [CrossRef]
- Chang, Y.T.; Lin, C.Y.; Chen, Y.H.; Hsueh, P.R. Update on infections caused by Stenotrophomonas maltophilia with particular attention to resistance mechanisms and therapeutic options. Front. Microbiol. 2015, 6, 893. [Google Scholar] [CrossRef]
- Mojica, M.F.; Humphries, R.; Lipuma, J.J.; Mathers, A.J.; Rao, G.G.; Shelburne, S.A.; Fouts, D.E.; Van Duin, D.; Bonomo, R.A. Clinical challenges treating Stenotrophomonas maltophilia infections: An update. JAC-Antimicrob. Resist. 2022, 4, dlac040. [Google Scholar] [CrossRef]
- Kullar, R.; Wenzler, E.; Alexander, J.; Goldstein, E.J.C. Overcoming Stenotrophomonas maltophilia Resistance for a More Rational Therapeutic Approach. Open Forum Infect. Dis. 2022, 9, ofac095. [Google Scholar] [CrossRef]
- Sarzynski, S.H.; Warner, S.; Sun, J.; Matsouaka, R.; Dekker, J.P.; Babiker, A.; Li, W.; Lai, Y.L.; Danner, R.L.; Fowler, V.G., Jr.; et al. Trimethoprim-Sulfamethoxazole versus Levofloxacin for Stenotrophomonas maltophilia Infections: A Retrospective Comparative Effectiveness Study of Electronic Health Records from 154 US Hospitals. Open Forum Infect. Dis. 2022, 9, ofab644. [Google Scholar] [CrossRef]
- Maraolo, A.E.; Cascella, M.; Corcione, S.; Cuomo, A.; Nappa, S.; Borgia, G.; De Rosa, F.G.; Gentile, I. Management of Multidrug-Resistant Pseudomonas aeruginosa in the Intensive Care Unit: State of the Art. Expert Rev. Anti Infect. Ther. 2017, 15, 861–871. [Google Scholar] [CrossRef]
- Ng, Q.X.; Ong, N.Y.; Lee, D.Y.X.; Yau, C.E.; Lim, Y.L.; Kwa, A.L.H.; Tan, B.H. Trends in Pseudomonas aeruginosa (P. aeruginosa) Bacteremia during the COVID-19 Pandemic: A Systematic Review. Antibiotics 2023, 12, 409. [Google Scholar] [CrossRef]
- Giacobbe, D.R.; Battaglini, D.; Enrile, E.M.; Dentone, C.; Vena, A.; Robba, C.; Ball, L.; Bartoletti, M.; Coloretti, I.; Di Bella, S.; et al. Incidence and Prognosis of Ventilator-Associated Pneumonia in Critically Ill Patients with COVID-19: A Multicenter Study. J. Clin. Med. 2021, 10, 555. [Google Scholar] [CrossRef] [PubMed]
- Schinas, G.; Polyzou, E.; Spernovasilis, N.; Gogos, C.; Dimopoulos, G.; Akinosoglou, K. Preventing Multidrug-Resistant Bacterial Transmission in the Intensive Care Unit with a Comprehensive Approach: A Policymaking Manual. Antibiotics 2023, 12, 1255. [Google Scholar] [CrossRef]
- Dalfino, L.; Stufano, M.; Bavaro, D.F.; Diella, L.; Belati, A.; Stolfa, S.; Romanelli, F.; Ronga, L.; Di Mussi, R.; Murgolo, F.; et al. Effectiveness of First-Line Therapy with Old and Novel Antibiotics in Ventilator-Associated Pneumonia Caused by Carbapenem-Resistant Acinetobacter baumannii: A Real Life, Prospective, Observational, Single-Center Study. Antibiotics 2023, 12, 1048. [Google Scholar] [CrossRef]
- Tiseo, G.; Brigante, G.; Giacobbe, D.R.; Maraolo, A.E.; Gona, F.; Falcone, M.; Giannella, M.; Grossi, P.; Pea, F.; Rossolini, G.M.; et al. Diagnosis and management of infections caused by multidrug-resistant bacteria: Guideline endorsed by the Italian Society of Infection and Tropical Diseases (SIMIT), the Italian Society of Anti-Infective Therapy (SITA), the Italian Group for Antimicrobial Stewardship (GISA), the Italian Association of Clinical Microbiologists (AMCLI) and the Italian Society of Microbiology (SIM). Int. J. Antimicrob. Agents 2022, 60, 106611. [Google Scholar] [CrossRef]
- Paul, M.; Carrara, E.; Retamar, P.; Tängdén, T.; Bitterman, R.; Bonomo, R.A.; de Waele, J.; Daikos, G.L.; Akova, M.; Harbarth, S.; et al. European Society of Clinical Microbiology and Infectious Diseases (ESCMID) guidelines for the treatment of infections caused by multidrug-resistant Gram-negative bacilli (endorsed by European society of intensive care medicine). Clin. Microbiol. Infect. 2022, 28, 521–547. [Google Scholar] [CrossRef]
- Gatti, M.; Pea, F. Jumping into the future: Overcoming pharmacokinetic/pharmacodynamic hurdles to optimize the treatment of severe difficult to treat-Gram-negative infections with novel beta-lactams. Expert Rev. Anti Infect. Ther. 2023, 21, 149–166. [Google Scholar] [CrossRef]
- Herrera, F.; Torres, D.; Laborde, A.; Berruezo, L.; Jordán, R.; Rossi, I.R.; Valledor, A.; Costantini, P.; Dictar, M.; Nenna, A.; et al. Development of a Clinical Score to Stratify the Risk for Carbapenem-Resistant Enterobacterales Bacteremia in Patients with Cancer and Hematopoietic Stem Cell Transplantation. Antibiotics 2023, 12, 226. [Google Scholar] [CrossRef] [PubMed]
- Cano, A.; Gutiérrez-Gutiérrez, B.; Machuca, I.; Gracia-Ahufinger, I.; Pérez-Nadales, E.; Causse, M.; Castón, J.J.; Guzman-Puche, J.; Torre-Giménez, J.; Kindelán, L. Risks of Infection and Mortality among Patients Colonized with Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae: Validation of Scores and Proposal for Management. Clin. Infect. Dis. 2018, 66, 1204–1210. [Google Scholar] [CrossRef]
- Giannella, M.; Bartoletti, M.; Morelli, M.C.; Tedeschi, S.; Cristini, F.; Tumietto, F.; Pasqualini, E.; Danese, I.; Campoli, C.; Lauria, N.D.; et al. Risk factors for infection with carbapenem-resistant Klebsiella pneumoniae after liver transplantation: The importance of pre- and posttransplant colonization. Am. J. Transplant. 2015, 15, 1708–1715. [Google Scholar] [CrossRef] [PubMed]
- Kitaya, S.; Kanamori, H.; Katori, Y.; Tokuda, K. Impact of Persistent Multidrug-Resistant Gram-Negative Bacteremia on Clinical Outcome and Mortality. Antibiotics 2023, 12, 313. [Google Scholar] [CrossRef]
- Kitaya, S.; Kanamori, H.; Baba, H.; Oshima, K.; Takei, K.; Seike, I.; Katsumi, M.; Katori, Y.; Tokuda, K. Clinical and Epidemiological Characteristics of Persistent Bacteremia: A Decadal Observational Study. Pathogens 2023, 12, 212. [Google Scholar] [CrossRef] [PubMed]
- López-Cortés, L.E.; Del Toro, M.D.; Gálvez-Acebal, J.; Bereciartua-Bastarrica, E.; Fariñas, M.C.; Sanz-Franco, M.; Natera, C.; Corzo, J.E.; Lomas, J.M.; Pasquau, J.; et al. Impact of an evidence-based bundle intervention in the quality-of-care management and outcome of Staphylococcus aureus bacteremia. Clin. Infect. Dis. 2013, 57, 1225–1233. [Google Scholar] [CrossRef]
- Huttner, B.D.; Sharland, M.; Huttner, A. On culture and blood cultures. Clin. Microbiol. Infect. 2023, 29, 1100–1102. [Google Scholar] [CrossRef]
- Kitaya, S.; Kanamori, H.; Katori, Y.; Tokuda, K. Clinical Characteristics and Outcomes of Persistent Staphylococcal Bacteremia in a Tertiary Care Hospital. Antibiotics 2023, 12, 454. [Google Scholar] [CrossRef] [PubMed]
- Kuehl, R.; Morata, L.; Boeing, C.; Subirana, I.; Seifert, H.; Rieg, S.; Kern, W.V.; Kim, H.B.; Kim, E.S.; Liao, C.H.; et al. Defining persistent Staphylococcus aureus bacteraemia: Secondary analysis of a prospective cohort study. Lancet Infect. Dis. 2020, 20, 1409–1417. [Google Scholar] [CrossRef] [PubMed]
- Lemonnier, D.; Machuel, M.; Obin, O.; Outurquin, G.; Adjidé, C.; Mullié, C. Trends in Antibiotic-Resistant Bacteria Isolated from Screening Clinical Samples in a Tertiary Care Hospital over the 2018–2022 Period. Antibiotics 2023, 12, 1314. [Google Scholar] [CrossRef]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the author. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Maraolo, A.E. Editorial for the Special Issue: “The Issue of Multidrug-Resistant Pathogens in Nosocomial Infections”. Antibiotics 2023, 12, 1683. https://doi.org/10.3390/antibiotics12121683
Maraolo AE. Editorial for the Special Issue: “The Issue of Multidrug-Resistant Pathogens in Nosocomial Infections”. Antibiotics. 2023; 12(12):1683. https://doi.org/10.3390/antibiotics12121683
Chicago/Turabian StyleMaraolo, Alberto Enrico. 2023. "Editorial for the Special Issue: “The Issue of Multidrug-Resistant Pathogens in Nosocomial Infections”" Antibiotics 12, no. 12: 1683. https://doi.org/10.3390/antibiotics12121683